-
Anthropic bans 'cruel' behavior against its Claude AI
-
US military to livestream firing squad execution of Fort Hood shooter
-
Anne Carson's Nobel literature prize 'a proud moment for Canada': PM
-
Aces star Wilson wins record-extending fifth WNBA MVP
-
Montagliani to seek CONCACAF re-election in boost for Infantino: reports
-
Undefeated 49ers seek Seahawks revenge
-
Oil surges, stocks sink on jitters over US plans in Iran war
-
Madrid mourns evicted retiree, 'icon' of Spain housing protests
-
John Cena and Jessica Biel hit the gas in 'Matchbox: The Movie'
-
OpenAI revenue gap report rattles AI stocks
-
US, Ukrainians, Europeans to discuss 'new ideas' to end war
-
France pledges more teachers after school students vow no let-up
-
Unproven 'cures' pushed online amid plague concerns
-
Bordeaux confirmed in sixth tier of French football
-
Nigeria looks to ease fuel prices as election looms
-
Trump gives 'national treasure' Musk top US medal after rift
-
Prosecutors in Maradona death trial seek sentences up to 12 years
-
MLB proposes shortening season, reforming playoffs
-
Swiss captain Xhaka gets suspended fine for fake Covid cert
-
Crew splashes down after 8-month mission on International Space Station
-
Ex-prince Andrew raid warrants ruled 'unlawful' but UK police maintain probe
-
Protests, clashes as S. African anti-migrant tensions reignite
-
Two Latvians arrested inside UK military base: police
-
Russian data centre hit by drone in first for Ukraine war
-
Eckert 'forever grateful' for Southampton support over spy scandal
-
'Fighting for our future': France high school students vow no let-up
-
Venezuela's Maduro, wife hit with new US torture charges
-
Kyiv entering 'survival' mode amid Russian strikes surge: mayor tells AFP
-
Argentina friendlies no fairy tale for African footballers
-
Verdict due in Mexico trial over murders of Australia, US surfers
-
US suspending Microsoft from visa program: Vance
-
B2PRIME Welcomes Christina Barbash as Commercial Manager
-
Man City must 'stick together' during crisis, says Haaland
-
Russia forcing Kyiv into 'survival' mode before winter, mayor tells AFP
-
CAS opens hearing into Senegal AFCON title appeal
-
Closing arguments begin in Maradona death trial
-
UK police agree searches for ex-prince Andrew's homes 'unlawful': judge
-
UEFA president Ceferin to stand for re-election in 2027
-
After botched US execution, Christa Pike walking, mentally 'foggy': lawyer
-
Nearly 300,000 Nepalis at flood risk: study
-
'Stunned' Madrid mourns pensioner who sparked housing protests
-
Riyadh kindergarten hit by interception debris as Houthis say targeted airport
-
High school students turn out for new protests across France
-
Alex Bodi mizează, alături de CRIF, pe investiții transparente și pe prevenirea riguroasă a spălării banilor
-
Bid by Italy's Intesa bank to take over MPS gets boost
-
Gulf Labs, Part of Thailand’s $27 Billion GULF Group, Goes Live as an Injective Validator
-
Stablecoins Are Quietly Becoming Business Infrastructure, NOWPayments Data Shows
-
EU okay for winter despite 'historically low' gas stocks: operators
-
Oil surges, stocks sink as US reportedly eyes new Iran strikes
-
Rwanda to host F1 Grand Prix: sources close to both sides
DATATRAK ePRO/eCOA Solution Expands Decentralized Trial Platform
Device‑agnostic ePRO that is BYOD (bring your own device) with email/SMS reminders, patient portals, and unified reporting across EDC and eDiaries
AUSTIN, TX / ACCESS Newswire / March 10, 2026 / DATATRAK Powered by Fountayn, a unified eClinical and decentralized clinical trial (DCT) platform, today announced the availability of its enhanced electronic patient‑reported outcomes (ePRO) and eCOA solution, designed to help sponsors, CROs, and sites collect high‑quality patient data for hybrid and decentralized clinical trials. Built on DATATRAK's core eClinical platform, the ePRO module can be deployed as a standalone solution or tightly integrated with the DATATRAK EDC to support end‑to‑end digital trials.
DATATRAK ePRO is a device‑agnostic, true BYOD solution that allows patients to use their own smartphones, tablets, or computers, reducing study costs and barriers to participation. Study teams can configure eDiaries and electronic clinical outcome assessments (eCOA) using the same eCRF design toolkit they rely on for EDC casebooks, enabling faster start‑up and consistent design across all data capture tools.
"Our customers want ePRO that is flexible, affordable, and fully connected to their EDC - not another silo," said Alex Tabatabai, CEO, DATATRAK Powered by Fountayn. "With DATATRAK ePRO, sponsors and CROs can design and launch eDiaries and eCOA quickly, send automated email and SMS reminders, and analyze compliance alongside EDC casebook data, all within a single, unified platform."
Standalone ePRO or Fully Integrated with EDC
DATATRAK's ePRO solution is built on the same core platform as its EDC, RTSM, CTMS, eTMF, and eConsent tools. Customers can:
Use ePRO as a standalone product and integrate with third‑party EDC or clinical trial systems, or
Add ePRO as a native extension of the DATATRAK EDC to create a unified environment for data capture, randomization, and trial operations.
Sites can invite and enroll ePRO participants directly from the EDC, link patient‑reported outcome data to subject records, and trigger one‑time notifications from within the EDC workflow. This tight integration helps reduce manual reconciliation and improves data quality across the study lifecycle.
Patient Engagement Through Email/SMS and Secure Portal
To support patient engagement and compliance, DATATRAK ePRO includes:
Email and SMS notifications to remind participants when eDiary or eCOA entries are due
A patient portal with secure PIN sign‑in so participants can easily access their tasks and forms
Configurable one‑time notifications sent from the EDC to specific participants or cohorts
These communication tools help improve completion rates and provide sites with better visibility into participant status in real time.
Unified Reporting Across eDiaries and EDC
Flexible reporting tools span both EDC casebooks and eDiaries, enabling study teams to build compliance and performance reports that incorporate patient‑reported outcomes alongside other clinical data. This unified view supports better decision‑making, early signal detection, and streamlined preparation for data reviews and regulatory inspections.
With databases hosted in key regions including the United States, Japan, and Europe -and options for additional local data hosting-DATATRAK Powered by Fountayn supports global studies while aligning with regional data privacy and security requirements.
About DATATRAK
Datatrak is transforming healthcare and life sciences through technological innovations from providing the first EDC technology to offering the first true eSource solution that seamlessly integrates all aspects of clinical trial data management including EDC, RTSM, RBM, eTMF, CTMS, ePRO, eConsent, Endpoint Adjudication, Imaging Data, Safety, Inventory Management, and Enterprise Management of Automated Alerts, Workflows, Documents, Timelines, and Global Oversight. No other company has been innovating in healthcare and life sciences as long as Datatrak. For over thirty years clinical trial professionals have trusted Datatrak for reliable and secure technology solutions. Datatrak complies with the highest Quality Assurance standards that are 21 CFR Part 11, GDPR, GCP, HIPAA, and CDISC compliant that are fully validated by our experienced team of software quality engineers. Datatrak's cloud-based platform is trusted in 83 countries, 6 continents, for over 10,000 clinical trials. Datatrak is based in Austin, Texas and has team members and data hosting infrastructure in its key service regions of the United States, Europe, and Japan. For more information, visit www.datatrak.com or www.fountayn.com.
Contact:
Sales Department
[email protected]
SOURCE: Datatrak International
View the original press release on ACCESS Newswire
A.Taylor--AT